BIOMAT Database Logo BIOMAT Database Logo

[Insulin binding to erythrocyte receptors in patients with essential hypertension]. 1999

J Głuszek, and L Szcześniak, and F Banaszak, and A Tykarski, and T Rychlewski
Klinika Nadciśnienia Tetniczego i Chorób Naczyń Instytutu Kardiologii AM w Poznaniu.

Recently many researchers have described the presence of insulin resistance and hyperinsulinemia in a substantial number of patients with essential hypertension. Reduced insulin binding to the receptors may play important role in development of insulin resistance in these patients. The study was aimed to assess the value of insulin binding to erythrocyte receptors in the patients with essential hypertension and compare to values in healthy persons. Additional purpose was the evaluation of insulin degradation by erythrocytes in patients with essential hypertension. 23 patients with essential hypertension (BMI 22.7 +/- 3.2) and 21 healthy persons (with BMI value 23.3 +/- 2.9) were studied. In all examined individuals the blood glucose and blood insulin concentrations were determined, insulin binding to erythrocyte receptors and insulin degradation by erythrocytes were measured by the method of Gambhir and al. Insulin concentration was significantly higher in patients with essential hypertension than in healthy subjects. We demonstrated a statistically significant positive correlation between body weight and insulin concentration in blood serum only in healthy people. Insulin binding to the receptors of red blood cells was significantly stronger (p < 0.001) in healthy persons than in patients with essential hypertension (0.972 +/- 0.395 pg 10(11) RBC and 0.446 +/- 0.14 pg 10(11) RBC respectively). In patients with hypertension insulin binding to receptors of red blood cells does not depend on body weight and insulin concentration in blood serum. Values of insulin degradation by erythrocyte in patients with essential hypertension and healthy persons were not significantly different. It seems that decreased insulin binding to insulin receptors is an important mechanism of insulin resistance patients with essential hypertension.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D004910 Erythrocyte Membrane The semi-permeable outer structure of a red blood cell. It is known as a red cell 'ghost' after HEMOLYSIS. Erythrocyte Ghost,Red Cell Cytoskeleton,Red Cell Ghost,Erythrocyte Cytoskeleton,Cytoskeleton, Erythrocyte,Cytoskeleton, Red Cell,Erythrocyte Cytoskeletons,Erythrocyte Ghosts,Erythrocyte Membranes,Ghost, Erythrocyte,Ghost, Red Cell,Membrane, Erythrocyte,Red Cell Cytoskeletons,Red Cell Ghosts
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J Głuszek, and L Szcześniak, and F Banaszak, and A Tykarski, and T Rychlewski
Diminished insulin receptors on erythrocyte ghosts in nonobese patients with essential hypertension independent of hyperinsulinemia.
July 1994, Journal of cardiovascular pharmacology,
J Głuszek, and L Szcześniak, and F Banaszak, and A Tykarski, and T Rychlewski
Improvement of insulin binding to erythrocyte insulin receptors in uraemia by haemodialysis.
January 1983, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association,
J Głuszek, and L Szcześniak, and F Banaszak, and A Tykarski, and T Rychlewski
Erythrocyte membrane properties in patients with essential hypertension.
January 2013, Cell biochemistry and biophysics,
J Głuszek, and L Szcześniak, and F Banaszak, and A Tykarski, and T Rychlewski
Binding characteristics of swine erythrocyte insulin receptors.
September 1985, American journal of veterinary research,
J Głuszek, and L Szcześniak, and F Banaszak, and A Tykarski, and T Rychlewski
Impaired insulin-mediated erythrocyte magnesium accumulation in essential hypertension.
November 1987, Clinical science (London, England : 1979),
J Głuszek, and L Szcześniak, and F Banaszak, and A Tykarski, and T Rychlewski
Altered calcium binding to erythrocyte membranes in essential hypertension: relation to magnesium.
February 1993, Journal of human hypertension,
J Głuszek, and L Szcześniak, and F Banaszak, and A Tykarski, and T Rychlewski
Absence of covalent binding by insulin to erythrocyte and reticulocyte insulin receptors.
September 1984, Biochemical and biophysical research communications,
J Głuszek, and L Szcześniak, and F Banaszak, and A Tykarski, and T Rychlewski
Detection of compounds in serum inhibiting insulin binding to erythrocyte receptors.
December 1988, Endocrinologia experimentalis,
J Głuszek, and L Szcześniak, and F Banaszak, and A Tykarski, and T Rychlewski
Erythrocyte insulin receptors in patients with chronic liver diseases.
January 1982, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
J Głuszek, and L Szcześniak, and F Banaszak, and A Tykarski, and T Rychlewski
Erythrocyte membrane lipid composition fluidity in patients with essential hypertension.
October 1992, Chinese medical journal,
Copied contents to your clipboard!